Effects of Herba Erigerontis injection on pharmacodynamics and pharmacokinetics of warfarin in rats in vivo
Authors:
- 6 November 2020
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 128 (3) , 386-393
Abstract
Herba Erigerontis injection (HEI) is an aqueous solution derived from whole plants of Erigeron breviscapus, which may be co‐administered with warfarin to treat cardiovascular and cerebrovascular disorders. This research was conducted to make sure whether HEI would affect anticoagulation of warfarin to guarantee reasonable medication. The pharmacodynamic study was designed to measure prothrombin time (PT) and activated partial thromboplastin time (APTT) values, and international normalized ratio (INR) values were calculated. For pharmacokinetic study, ultra performance liquid chromatography‐tandem mass spectrometer (UPLC‐MS/MS) technology was applied to measure plasma concentrations of warfarin enantiomers. The influence of HEI on plasma protein binding rate of warfarin was assessed by ultrafiltration. Pharmacodynamic study demonstrated that both HEI alone and co‐administered with warfarin could increase PT and INR values significantly (P < .01), whereas the APTT values were unaffected (P > .05). Pharmacokinetic study manifested that Cmax, AUC and t1/2 prolonged significantly (P < .01) for R/S‐warfarin in presence of HEI. Low (3.6 mL/kg), medium (7.2 mL/kg) and high (10.8 mL/kg) doses of HEI could decrease plasma protein binding rate of warfarin significantly (P < .01). The results mean that HEI can potentiate the anticoagulant response of warfarin through both pharmacodynamics and pharmacokinetics.Keywords
Funding Information
- National Natural Science Foundation of China (81173659)
This publication has 23 references indexed in Scilit:
- Review on mechanisms and interactions in concomitant use of herbs and warfarin therapyBiomedicine & Pharmacotherapy, 2016
- Effect of gene polymorphims on the warfarin treatment at initial stageThe Pharmacogenomics Journal, 2015
- Rapid screening and identification of caffeic acid and its esters in Erigeron breviscapus by ultra‐performance liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2010
- A Rapid Method for Qualitative and Quantitative Analysis of Major Constituents in Dengzhanxixin Injection by LC-DAD-ESI–MSnChromatographia, 2010
- Death and Disability from Warfarin-Associated Intracranial and Extracranial HemorrhagesThe American Journal of Medicine, 2007
- Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper WallJournal of Ethnopharmacology, 2006
- Simultaneous determination of active ingredients in Erigeron breviscapus (Vant.) Hand-Mazz. by capillary electrophoresis with electrochemical detectionJournal of Pharmaceutical and Biomedical Analysis, 2005
- A Study of the Cardioprotective Effect of Breviscapine During Hypoxia of Cardiomyocytesin vitroand During Myocardial Infarctionin vivoPlanta Medica, 2004
- Roles of two allelic variants (Arg144Cys and Ile359Leu) of cytochrome P4502C9 in the oxidation of tolbutamide and warfarin by human liver microsomesXenobiotica, 1998
- Human P450 metabolism of warfarinPharmacology & Therapeutics, 1997